Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10626087
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
granted -
US 10620204
Antibody-mediated neutralization of Ebola viruses
granted -
US 10617709
miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
granted -
US 10618869
Oligo-benzamide compounds and their use
granted -
US 10603311
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
granted -
US 10598665
Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
granted -
US 10596247
Methods and compositions for attenuated chlamydia as vaccine and vector
granted -
US 10590171
Exosomes and methods of making and using the same
granted -
US 10589003
Methods for coating surfaces with antimicrobial agents
granted -
US 10583145
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 10583134
Methods and therapeutic combinations for treating tumors
granted -
US 10577344
Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins
granted -
US 10576096
Tumor-selective combination therapy
granted -
US 10570183
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 10570186
Chimeric antigen receptors (CAR) to selectively target protein complexes
granted -
US 10570382
Transposase polypeptides and uses thereof
granted -
US 10569067
Controlled release nanoparticulate matter delivery system
granted -
US 10561763
Oxygen generating biomaterial
granted -
US 10562849
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
granted -
US 10563204
Methods of treating cancer harboring hemizygous loss of TP53
granted -
US 10537635
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted -
US 10538762
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat
granted -
US 10538579
Bispecific pertussis antibodies
granted -
US 10533186
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
granted